We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

160 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 57 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

19% more capital invested

Capital invested by funds: $405M → $483M (+$77.5M)

5% more funds holding

Funds holding: 153 → 160 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 57

45% less call options, than puts

Call options by funds: $1.89M | Put options by funds: $3.46M

Holders
160
Holders Change
+7
Holders Change %
+4.58%
% of All Funds
4.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
56
Reduced
57
Closed
15
Calls
$1.89M
Puts
$3.46M
Net Calls
-$1.56M
Net Calls Change
-$368K

Top Buyers

1
RIM
Ranger Investment Management
Texas
+$15.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$12.6M
3
BTW
Boston Trust Walden
Massachusetts
+$12.3M
4
LCP
Lombardia Capital Partners
California
+$5.5M
5
BFA
BlackRock Fund Advisors
California
+$2.93M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$8.04M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$5.7M
3
Morgan Stanley
Morgan Stanley
New York
-$4.66M
4
NI
Numeric Investors
Massachusetts
-$3.26M
5
TC
TFS Capital
Pennsylvania
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$1.63M -$6.8K -174 -0.4%
ARTA
52
A.R.T. Advisors
New York
$1.63M +$176K +4,502 +13%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$1.61M +$557K +14,242 +56%
JMPWA
54
JP Morgan Private Wealth Advisors
California
$1.44M – – –
Invesco
55
Invesco
Georgia
$1.42M -$145K -3,705 -10%
GC
56
Guggenheim Capital
Illinois
$1.27M -$80.4K -2,057 -6%
Goldman Sachs
57
Goldman Sachs
New York
$1.24M -$679K -17,367 -36%
PWLP
58
Prio Wealth Limited Partnership
Massachusetts
$1.22M – – –
Comerica Bank
59
Comerica Bank
Texas
$1.14M +$541K +13,852 +97%
Public Sector Pension Investment Board (PSP Investments)
60
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.11M – – –
CCIA
61
Campbell & Co Investment Adviser
Maryland
$1.09M -$845K -21,625 -45%
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$1.09M +$4.46K +114 +0.4%
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$1.06M +$362K +9,256 +55%
FQ
64
First Quadrant
California
$1.03M – – –
UBS Group
65
UBS Group
Switzerland
$984K +$944K +24,161 New
VFA
66
Virtus Fund Advisers
Connecticut
$928K +$4.3K +110 +0.5%
WCM
67
Wedge Capital Management
North Carolina
$921K – – –
MERSOM
68
Municipal Employees' Retirement System of Michigan
Michigan
$921K +$379K +9,700 +75%
DM
69
Diker Management
New York
$883K -$10.4K -265 -1%
SO
70
STRS Ohio
Ohio
$847K +$11.7K +300 +1%
Los Angeles Capital Management
71
Los Angeles Capital Management
California
$827K +$295K +7,555 +59%
AllianceBernstein
72
AllianceBernstein
Tennessee
$811K – – –
Axa
73
Axa
France
$803K +$489K +12,500 +174%
OSAM
74
O'Shaughnessy Asset Management
Connecticut
$784K -$797K -20,391 -51%
RFC
75
Russell Frank Company
Washington
$780K +$689K +17,637 +1,143%
1 2
3
4 5

ANIK Hedge Fund Activity: Q4 2014 in Review

160 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q4 2014, worth a combined $483M — up 19% from $405M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ANIK positions and 15 closed out — a net gain of 10 holders — while 56 added to existing stakes and 57 trimmed.

The largest buyer was Ranger Investment Management, adding an estimated $15.4M. The largest seller was Millennium Management, cutting an estimated $8.04M.

  • 160 institutional investors held Anika Therapeutics (ANIK) as of Q4 2014, up from 153 in Q3 2014.
  • Funds reported $483M of Anika Therapeutics stock for Q4 2014, up 19% quarter-over-quarter.
  • 25 funds opened new Anika Therapeutics positions in Q4 2014 and 15 closed out, a net change of +10 holders.
  • The largest Anika Therapeutics buyer in Q4 2014 was Ranger Investment Management, an estimated $15.4M added.
  • The largest Anika Therapeutics seller in Q4 2014 was Millennium Management, an estimated $8.04M sold.

Based on aggregated 13F filings for Q4 2014.